HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 280, Issue 24, 23390-23396, June 17, 2005

This Article Full Text Full Text (PDF) All Versions of this Article: 280/24/23390    most recent M502777200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lan, D. Articles by Silver, D. L. Search for Related Content PubMed PubMed Citation Articles by Lan, D. Articles by Silver, D. L. Social Bookmarking                      What's this?

Fenofibrate Induces a Novel Degradation Pathway for Scavenger Receptor B-I Independent of PDZK1^*

Debin Lan and David L. Silver

From the Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York 10032

Fibrate drugs improve cardiovascular health by lowering plasma triglycerides, normalize low density lipoprotein levels, and raise high density lipoprotein (HDL) levels in patients with dyslipidemias. The HDL-raising effect of fibrates has been shown to be due in part to an increase in human apolipoprotein AI gene expression. However, it has recently been shown that fibrates can affect HDL metabolism in mouse by significantly decreasing hepatic levels of the HDL receptor scavenger receptor B-I (SR-BI) and the PDZ domain containing protein PDZK1. PDZK1 is essential for maintaining hepatic SR-BI levels. Therefore, decreased SR-BI might be secondary to decreased PDZK1, but the mechanism by which fibrates lower SR-BI has not been elucidated. Here we show that feeding PDZK1-deficient mice fenofibrate resulted in the near absence of SR-BI in liver, definitively demonstrating that the effect of fenofibrate on SR-BI is PDZK1-independent. Metabolic labeling experiments in primary hepatocytes from fenofibrate-fed mice demonstrated that fenofibrate enhanced the degradation of SR-BI in a post-endoplasmic reticulum compartment. Moreover, fenofibrate-induced degradation of SR-BI was independent of the proteasome, calpain protease, or the lysosome, and antioxidants did not inhibit fenofibrate-induced degradation of SR-BI. Using metabolic labeling coupled with cell surface biotinylation assays, fenofibrate did not inhibit SR-BI trafficking to the plasma membrane. Together, the data support a model in which fenofibrate enhances the degradation of SR-BI in a post-ER, post-plasma membrane compartment. The further elucidation of this novel degradation pathway may provide new insights into the physiological and pathophysiological regulation of hepatic SR-BI.

Received for publication, March 14, 2005 , and in revised form, April 15, 2005.

^* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: College of Physicians and Surgeons, Room 8-401, Columbia University, New York, NY 10032. Tel.: 212-342-1320; Fax: 212-305-5052; E-mail: dls51{at}columbia.edu.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T. Sugiura, Y. Kato, T. Wakayama, D. L. Silver, Y. Kubo, S. Iseki, and A. Tsuji PDZK1 Regulates Two Intestinal Solute Carriers (Slc15a1 and Slc22a5) in Mice Drug Metab. Dispos., June 1, 2008; 36(6): 1181 - 1188. [Abstract] [Full Text] [PDF]

				W. Zhu, S. Saddar, D. Seetharam, K. L. Chambliss, C. Longoria, D. L. Silver, I. S. Yuhanna, P. W. Shaul, and C. Mineo The Scavenger Receptor Class B Type I Adaptor Protein PDZK1 Maintains Endothelial Monolayer Integrity Circ. Res., February 29, 2008; 102(4): 480 - 487. [Abstract] [Full Text] [PDF]

				J. Glaysher and C. Van Heyningen Paradoxical decrease in high density lipoprotein-cholesterol associated with statin and fenofibrate combination therapy The British Journal of Diabetes & Vascular Disease, November 1, 2007; 7(6): 295 - 297. [PDF]

				S. Shetty, E. R.M. Eckhardt, S. R. Post, and D. R. van der Westhuyzen Phosphatidylinositol-3-Kinase Regulates Scavenger Receptor Class B Type I Subcellular Localization and Selective Lipid Uptake in Hepatocytes Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 2125 - 2131. [Abstract] [Full Text] [PDF]

				P. Wang, J. J. Wang, Y. Xiao, J. W. Murray, P. M. Novikoff, R. H. Angeletti, G. A. Orr, D. Lan, D. L. Silver, and A. W. Wolkoff Interaction with PDZK1 Is Required for Expression of Organic Anion Transporting Protein 1A1 on the Hepatocyte Surface J. Biol. Chem., August 26, 2005; 280(34): 30143 - 30149. [Abstract] [Full Text] [PDF]